Michael Fink, the Vice-President of PhageEU, is also the CEO of two companies, Phage Technology Center GmbH and FinkTec GmbH.
He is a Chemist and a Chemical Engineer by education with more than 20 years of experience in the area of farm to fork food safety with focus on product development and regulatory strategy in the food, milk, beer and beverage industry as well as in the dairy and life stock farming sector.
With this background and a passion for applied science, in 2013 he started to explore the use of bacteriophages as new approach to overcome existing problems in the above-mentioned fields.
His diverse expertise and commitment to lead his interdisciplinary teams to develop novel products and solutions, while always keeping a way for market authorisation in mind.
In his leadership within the cooperate boundaries, he is convinced that there is the demand for collaboration of the entire industry, the legislators and all other stake holders to bring bacteriophage technology, in all its different application facets, into a broad use. In some areas the legal basis for the specific use of bacteriophages is being developed and therefore it is important to support this process as the biotech / bacteriophage industry with all its very specific Know How.
He envisages a big contribution of bacteriophage technology to improve food safety, to make feed safer, in the reduction of food waste and to have an alternative strategy to reduce antibiotic use in different life stock applications.
